Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Late-Stage Pipeline

25%

1 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A
3(75.0%)
Phase 4
1(25.0%)
4Total
N/A(3)
Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT05964192Not ApplicableRecruiting

Added Value of a Neuroendocrine Test Battery in the Response to Repetitive Transcranial Magnetic Stimulation (rTMS) Treatment

Role: lead

NCT05813756Not ApplicableUnknown

Validation Study of the Coping, Motivation and Post-diagnosis Psychoeducation Program for Adults With Autism

Role: lead

NCT03491696Phase 4Unknown

Effects of the Addition of Metyrapone to Antidepressant Therapy in Depression With Dexamethasone Suppression Test Non-suppression.

Role: lead

NCT03411434Not ApplicableUnknown

Added Value of the Oculomotor and Cognitive Examination in the Management of Patients With ADHD

Role: lead

All 4 trials loaded